{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:17:27Z","timestamp":1790698647912,"version":"4.1.0"},"reference-count":41,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2019,7,25]]},"abstract":"<jats:sec><jats:title>:<\/jats:title><jats:p>While Behavioral Therapy (BT) should be recommended as the first step in the treatment of OCD as well as TS, medication can be added for augmentation and in certain situations (e.g. family preference, BT not available or feasible) the priority may even reverse. This narrative review is given on the complexity of drug treatment in patients comorbid with obsessive-compulsive disorder (OCD) and Tourette syndrome (TS) and other tic problems. OCD with TS is a co-occurring combination of the two generally delimitable, but in detail, also overlapping disorders which wax and wane with time but have different courses as well as necessities and options of treatment. Distinct subtypes like \u201ctic-related OCD\u201d are questionable. Obsessive-compulsive symptoms (OCS) and tics are frequently associated (OCS in TS up to 90%, tics in OCD up to 37%). Sensory-motor phenomena like urges and just-right feelings reflect some behavioral overlap. The main additional psychopathologies are attention-deficit hyperactivity disorder (ADHD), mood problems and anxiety. Also, hair pulling disorder and skin picking disorder are related to OCD with TS. Hence, the assessment and drug treatment of its many psychopathological problems need high clinical experience, careful planning, and ongoing evaluation\/adaptation. Drugs are able to reduce clinical symptoms but cannot cure the disorders, which should be treated in parallel in their own right; i.e. for OCD serotonin reuptake inhibitors (SSRI) and for TS (tics), certain antipsychotics can be successfully prescribed. In cases of OCD with tics, when OCS responds only partially, an augmentation with antipsychotics (recommended: risperidone and aripiprazole) may improve OCS as well as tics. Also, the benzamide sulpiride, an atypical antipsychotics, may be beneficial in treating the combination of OCS, tics and anxious-depressive problems.<\/jats:p><\/jats:sec><jats:sec><jats:title>:<\/jats:title><jats:p>Probably, any additional psychopathologies of OCD might attenuate the effectiveness of SSRI on OCS; on the other hand, in cases of OCD with tics, SSRI may reduce not only OCS but also stress sensitivity and emotional problems and thus leading to better selfregulatory abilities, useful to improve tic suppression.<\/jats:p><\/jats:sec><jats:sec><jats:title>:<\/jats:title><jats:p>In sum, some clinical guidance can be given, but there remain many uncertainties because of a scarce database for psychopharmacotherapy in OCD with TS.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1570159x16666180828095131","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T12:03:16Z","timestamp":1535457796000},"page":"703-709","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Psychopharmacotherapy of Obsessive-Compulsive Symptoms within the Framework of Tourette Syndrome"],"prefix":"10.2174","volume":"17","author":[{"given":"Aribert","family":"Rothenberger","sequence":"first","affiliation":[{"name":"Clinic for Child and Adolescent Psychiatry and Psychotherapy, University Medical Center Gottingen, Gottingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Roessner","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Psychiatry and Psychotherapy, TU Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"16097","DOI":"10.1038\/nrdp.2016.97","volume":"3","author":"Robertson M.M.","year":"2017","unstructured":"Robertson MM, Eapen V, Singer HS, Martino D, Scharf JM, Paschou P, Roessner V, Woods DW, Hariz M, Mathews CA, \u010crn\u010dec R, Leckman JF. Nat Rev Dis Primers, Gilles de la Tourette syndrome.,, 2017, 3,, 16097-,[http:\/\/dx.doi. org\/10.1038\/nrdp.2016.97]. [PMID: 28150698].","journal-title":"Nat Rev Dis Primers"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00787-016-0936-0","volume":"26","author":"H\u00f8jgaard D.R.M.A.","year":"2017","unstructured":"H\u00f8jgaard DRMA, Skarphedinsson G, Nissen JB, Hybel KA, Ivarsson T, Thomsen PH. Eur Child Adolesc Psychiatry, Pediatric obsessive-compulsive disorder with tic symptoms: clinical presentation and treatment outcome.,, 2017, 26,, 681-689,[http:\/\/dx.doi.org\/10.1007\/s00787-016-0936-0]. [PMID: 28032202].","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jaac.2014.09.014","volume":"53","author":"Conelea C.A.","year":"2014","unstructured":"Conelea CA, Walther MR, Freeman JB, Garcia AM, Sapyta J, Khanna M, Franklin M. J Am Acad Child Adolesc Psychiatry, Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II.,, 2014, 53,, 1308-1316,[http:\/\/dx.doi. org\/10.1016\/j.jaac.2014.09.014]. [PMID: 25457929].","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jbtep.2015.03.004","volume":"49","author":"Bennet S.","year":"2015","unstructured":"Bennet S, Stark D, Shafran R, Heyman I, Krebs G. Behav Ther Exp Psychiatry, Evaluation of cognitive behavior therapy for paediatric obsessive-compulsive disorder in the context of tic disorders.,, 2015, 49,, 223-229,[http:\/\/dx.doi.org\/10.1016\/j. jbtep.2015.03.004].","journal-title":"Behav Ther Exp Psychiatry"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neulet.2006.04.021","volume":"403","author":"Moll G.H.","year":"2006","unstructured":"Moll GH, Heinrich H, Gevensleben H, Rothenberger A. Neurosci Lett, Tic distribution and inhibitory processes in the sensorimotor circuit during adolescence: a cross-sectional TMS study.,, 2006, 403,, 96-99,[http:\/\/dx.doi.org\/10.1016\/j.neulet.2006.04. 021]. [PMID: 16690208].","journal-title":"Neurosci Lett"},{"key":"ref=6","first-page":"26","author":"Rothenberger A.","year":"2013","unstructured":"Rothenberger A, Roessner V. The phenomenology of attention-deficit \/hyperactivity disorder in Tourette Syndrome Tourette Syndrome; Martino, D, ,, 2013, 403,, 26-49,[http:\/\/dx.doi.org\/10.1093\/ med\/9780199796267.003.0002]","journal-title":"The phenomenology of attention-deficit \/hyperactivity disorder in Tourette Syndrome Tourette Syndrome; Martino, D"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/978-3-7091-1501-5_27","author":"Roessner V.","year":"2014","unstructured":"Roessner V, Rothenberger A. Tic disorders Psychiatric drugs in children and adolescents; Gerlach, M; Warnke, M, ,, 2014, 403,, 517-525,","journal-title":"Tic disorders Psychiatric drugs in children and adolescents; Gerlach, M; Warnke, M"},{"key":"ref=8","first-page":"50","author":"Ferrao Y.A.","year":"2013","unstructured":"Ferrao YA, de Alvarenga PG, Hounie AG, de Mathis MA, de Rosario MC, Miguel EC. The phenomenology of obsessive-compulsive symptoms in Tourette Syndrome Tourette Syndrome; Martino, D, ,, 2013, 403,, 50-73,[http:\/\/dx.doi.org\/10.1093\/med\/ 9780199796267.003.0003]","journal-title":"The phenomenology of obsessive-compulsive symptoms in Tourette Syndrome Tourette Syndrome; Martino, D"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"e1240","DOI":"10.4088\/JCP.14m09736","volume":"77","author":"de Vries F.E.","year":"2016","unstructured":"de Vries FE, Cath DC, Hoogendoorn AW, van Oppen P, Glas G, Veltman DJ, van den Heuvel OA, van Balkom AJ. J Clin Psychiatry, Tic-related versus tic-free obsessive-compulsive disorders: clinical picture and 2-year natural course.,, 2016, 77,, e1240-e1247,[http:\/\/dx.doi.org\/10.4088\/JCP.14m09736]. [PMID: 27631146].","journal-title":"J Clin Psychiatry"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1469-8749.2003.tb00873.x","volume":"45","author":"Banaschewski T.","year":"2003","unstructured":"Banaschewski T, Woerner W, Rothenberger A. Dev Med Child Neurol, Premonitory sensory phenomena and suppressibility of tics in Tourette syndrome: developmental aspects in children and adolescents.,, 2003, 45,, 700-703,[http:\/\/dx.doi.org\/10.1111\/j. 1469-8749.2003.tb00873.x]. [PMID: 14515942].","journal-title":"Dev Med Child Neurol"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fnins.2016.00415","volume":"10","author":"Sambrani T.","year":"2016","unstructured":"Sambrani T, Jakubovski E, M\u00fcller-Vahl KR. Front Neurosci, New insights into clinical characteristics of Gilles de la Tourette syndrome: findings in 1032 patients from a single German center.,, 2016, 10,, 415-,[http:\/\/dx.doi.org\/10.3389\/fnins.2016.00415]. [PMID: 27672357].","journal-title":"Front Neurosci"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jamapsychiatry.2014.2650","volume":"72","author":"Hirschtritt M.W.","year":"2015","unstructured":"Hirschtritt MW, Lee PC, Pauls D, Dion Y, Grados M, Illman C, King RA, Sandor P, Mc Mahon WM, Lyon GL, Cath DC, Kurlan R, Robertson MM, Osiecki L, Scharf JM, Mathews CA. JAMA Psychiatry, Tourette Syndrome Association International Consortium for Genetics. Lifetime prevalence, age of risk, and etiology of comorbid psychiatric disorders in Tourette Syndrome.,, 2015, 72,, 325-333,[http:\/\/dx.doi.org\/10.1001\/ jamapsychiatry.2014.2650]. [PMID: 25671412].","journal-title":"JAMA Psychiatry"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00787-013-0407-9","volume":"22","author":"Rothenberger A.","year":"2013","unstructured":"Rothenberger A, Becker A, Rothenberger LG. Eur Child Adolesc Psychiatry, Core features and associated psychopathology of Tourette syndrome: Modifications by cultural aspects?,, 2013, 22,, 709-711,[http:\/\/dx.doi.org\/10.1007\/s00787-013-0407-9]. [PMID: 23568421].","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jocrd.2014.04.003","volume":"3","author":"Eddy C.M.","year":"2014","unstructured":"Eddy CM, Cavanna AE. J Obsessive Compuls Relat Disord, Tourette syndrome and obsessive compulsive disorder: Compulsivity along the continuum.,, 2014, 3,, 363-371,[http:\/\/dx.doi.org\/10. 1016\/j.jocrd.2014.04.003].","journal-title":"J Obsessive Compuls Relat Disord"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neurol.2018.01.364","volume":"174","author":"Hartmann A.","year":"2018","unstructured":"Hartmann A, Millet B. Rev Neurol (Paris), Repetitive movements and behaviors in neurological and psychiatric practice: Distinctions and similarities between Tourette disorder and obsessive-compulsive disorder.,, 2018, 174,, 199-202,[http:\/\/dx.doi.org\/10.1016\/ j.neurol.2018.01.364]. [PMID: 29606319].","journal-title":"Rev Neurol (Paris)"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1024\/1422-4917\/a000229","volume":"41","author":"Roessner V.","year":"2013","unstructured":"Roessner V, Buse J, Schultze F, Rothenberger A, Becker A. Z Kinder Jugendpsychiatr Psychother, The role of obsessive-compulsive symptoms in the psychopathological profile of children with chronic tic disorder and attention-deficit hyperactivity disorder.,, 2013, 41,, 163-169,[http:\/\/dx.doi.org\/10.1024\/1422-4917\/ a000229]. [PMID: 23639924].","journal-title":"Z Kinder Jugendpsychiatr Psychother"},{"key":"ref=17","first-page":"524","author":"Roessner V.","year":"2013","unstructured":"Roessner V, Rothenberger A. Pharmacological treatment of tics Tourette Syndrome; Martino, D, ,, 2013, 41,, 524-552,[http:\/\/ dx.doi.org\/10.1093\/med\/9780199796267.003.0024]","journal-title":"Pharmacological treatment of tics Tourette Syndrome; Martino, D"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00787-017-1074-z","volume":"27","author":"Greenberg E.","year":"2018","unstructured":"Greenberg E, Tung ES, Gauvin C, Osiecki L, Yang KG, Curley E, Essa A, Illmann C, Sandor P, Dion Y, Lyon GJ, King RA, Darrow S, Hirschtritt ME, Budman CL, Grados M, Pauls DL, Keuthen NJ, Mathews CA, Scharf JM. Eur Child Adolesc Psychiatry, Prevalence and predictors of hair pulling disorder and excoriation disorder in Tourette syndrome.,, 2018, 27,, 569-579,[http:\/\/dx.doi.org\/10.1007\/s00787-017-1074-z]. [PMID: 29098466].","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005053-199804000-00001","volume":"186","author":"Coffey B.J.","year":"1998","unstructured":"Coffey BJ, Miguel EC, Biederman J, Baer L, Rauch SL, O\u2019Sullivan RL, Savage CR, Phillips K, Borgman A, Green-Leibovitz MI, Moore E, Park KS, Jenike MA. J Nerv Ment Dis, Tourette\u2019s disorder with and without obsessive-compulsive disorder in adults: are they different?,, 1998, 186,, 201-206,[http:\/\/dx.doi.org\/10.1097\/00005053-199804000-00001]. [PMID: 9569887].","journal-title":"J Nerv Ment Dis"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s10578-015-0550-2","volume":"47","author":"Rozenman M.","year":"2016","unstructured":"Rozenman M, Peris TS, Gonzalez A, Piacentini J. Child Psychiatry Hum Dev, Clinical characteristics of pediatric trichotillomania: comparisons with obsessive-compulsive and tic disorders.,, 2016, 47,, 124-132,[http:\/\/dx.doi.org\/10.1007\/s10578-015-0550-2]. [PMID: 25894516].","journal-title":"Child Psychiatry Hum Dev"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaac.2017.01.010","volume":"56","author":"Groth C.","year":"2017","unstructured":"Groth C, Mol Debes N, Rask CU, Lange T, Skov L. J Am Acad Child Adolesc Psychiatry, Course of Tourette Syndrome and comorbidities in a large prospective clinical study.,, 2017, 56,, 304-312,[http:\/\/dx.doi.org\/10.1016\/j.jaac.2017.01.010]. [PMID: 28335874].","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref=22","first-page":"B5465","volume":"65","author":"Groth C.","year":"2018","unstructured":"Groth C. Dan Med J, Tourette syndrome in a longitudinal perspective. Clinical course of tics and comorbidities, coexisting psychopathologies, phenotypes and predictors.,, 2018, 65,, B5465-,[PMID: 29619935].","journal-title":"Dan Med J"},{"key":"ref=23","first-page":"107","author":"Bloch M.","year":"2013","unstructured":"Bloch M. Clinical course and adult outcome in Tourette Syndrome Tourette Syndrome; Martino, D, ,, 2013, 65,, 107-120,[http:\/\/dx.doi.org\/10.1093\/med\/9780199796267.003.0005]","journal-title":"Clinical course and adult outcome in Tourette Syndrome Tourette Syndrome; Martino, D"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nicl.2016.11.013","volume":"13","author":"Naaijen J.","year":"2016","unstructured":"Naaijen J, Forde NJ, Lythgoe DJ, Akkermans SEA, Openneer TJ, Dietrich A, Zwiers MP, Hoekstra PJ, Buitelaar JK. Neuroimage Clin, Fronto-striatal glutamate in children with Tourette\u2019s disorder and attention-deficit\/hyperactivity disorder.,, 2016, 13,, 16-23,[http:\/\/dx.doi.org\/10.1016\/j.nicl.2016.11.013]. [PMID: 27909683].","journal-title":"Neuroimage Clin"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1024\/1422-4917\/a000546","volume":"46","author":"Mechler K.","year":"2018","unstructured":"Mechler K, H\u00e4ge A, Schweinfurth N, Glennon TC, Dijkhuisen RM, Murphy D, Durston S, Williams S, Buitelaar JK, Banaschewski T, Dittmann RW. Z Kinder Jugendpsychiatr, Glutamatergic agents in the treatment of compulsivity and impulsivity in child and adolescent psychiatry: a systematic review oft he literature.,TACTICS Consortium, 2018, 46,, 246-263,[http:\/\/ dx.doi.org\/10.1024\/1422-4917\/a000546]. [PMID: 28922069].","journal-title":"Z Kinder Jugendpsychiatr"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12888-014-0317-5","volume":"14","author":"Veale D.","year":"2014","unstructured":"Veale D, Miles S, Smallcombe N, Ghezai H, Goldacre B, Hodsoll J. BMC Psychiatry, Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.,, 2014, 14,, 317-,[http:\/\/dx.doi.org\/ 10.1186\/s12888-014-0317-5]. [PMID: 25432131].","journal-title":"BMC Psychiatry"},{"key":"ref=27","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv047","volume":"18","author":"Dold M.","year":"2015","unstructured":"Dold M, Aigner M, Lanzenberger R, Kasper S. Int J Neuropsychopharmacol, Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: An updated meta-analysis of double-blind, randomized, placebo-controlled trials.,, 2015, 18,, 317-,[http:\/\/dx.doi.org\/10.1093\/ ijnp\/pyv047]. [PMID: 25939614].","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=28","first-page":"69","volume":"69","author":"Roessner V.","year":"2005","unstructured":"Roessner V, Becker A, Banaschewski T, Rothenberger A. J Neural Transm Suppl, Tic disorders and obsessive compulsive disorder: where is the link?,, 2005, 69,, 69-99,[PMID: 16355604].","journal-title":"J Neural Transm Suppl"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/jcpp.12556","volume":"57","author":"Whittington C.","year":"2016","unstructured":"Whittington C, Pennant M, Kendall T, Glazebrook C, Trayner P, Groom M, Hedderly T, Heyman I, Jackson G, Jackson S, Murphy T, Rickards H, Robertson M, Stern J, Hollis C. J Child Psychol Psychiatry, Practitioner review: Treatments for tourette syndrome in children and young people - a systematic review.,, 2016, 57,, 988-1004,[http:\/\/dx.doi.org\/10.1111\/jcpp. 12556]. [PMID: 27132945].","journal-title":"J Child Psychol Psychiatry"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neubiorev.2015.12.013","volume":"63","author":"Yang C.","year":"2016","unstructured":"Yang C, Hao Z, Zhu C, Guo Q, Mu D, Zhang L. Neurosci Biobehav Rev, Interventions for tic disorders: An overview of systematic reviews and meta analyses.,, 2016, 63,, 239-255,[http:\/\/dx. doi.org\/10.1016\/j.neubiorev.2015.12.013]. [PMID: 26751711].","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2012.05.043","volume":"68","author":"Roessner V.","year":"2013","unstructured":"Roessner V, Schoenefeld K, Buse J, Bender S, Ehrlich S, M\u00fcnchau A. Neuropharmacology, Pharmacological treatment of tic disorders and Tourette Syndrome.,, 2013, 68,, 143-149,[http:\/\/dx.doi. org\/10.1016\/j.neuropharm.2012.05.043]. [PMID: 22728760].","journal-title":"Neuropharmacology"},{"key":"ref=32","first-page":"553","author":"Cardona F.","year":"2013","unstructured":"Cardona F, Rizzo R. Treatment of psychiatric comorbidities in Tourette syndromes Tourette Syndrome; Martino, D, ,, 2013, 68,, 553-582,[http:\/\/dx.doi.org\/10.1093\/med\/9780199796267.003.0025]","journal-title":"Treatment of psychiatric comorbidities in Tourette syndromes Tourette Syndrome; Martino, D"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/B978-0-12-411546-0.00013-5","volume":"112","author":"Neri V.","year":"2013","unstructured":"Neri V, Cardona F. Int Rev Neurobiol, Clinical pharmacology of comorbid obsessive-compulsive disorder in Tourette syndrome.,, 2013, 112,, 391-414,[http:\/\/dx.doi.org\/10.1016\/B978-0-12-411546-0.00013-5]. [PMID: 24295628].","journal-title":"Int Rev Neurobiol"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00004714-199310000-00008","volume":"13","author":"McDougle C.J.","year":"1993","unstructured":"McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH. J Clin Psychopharmacol, The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.,, 1993, 13,, 354-358,[http:\/\/dx.doi.org\/ 10.1097\/00004714-199310000-00008]. [PMID: 8227493].","journal-title":"J Clin Psychopharmacol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jpsychires.2006.05.007","volume":"41","author":"Husted D.S.","year":"2007","unstructured":"Husted DS, Shapira NA, Murphy TK, Mann GD, Ward HE, Goodman WK. J Psychiatr Res, Effect of comorbid tics on a clinically meaningful response to 8-week open-label trial of fluoxetine in obsessive compulsive disorder.,, 2007, 41,, 332-337,[http:\/\/dx.doi.org\/10.1016\/j.jpsychires.2006.05.007]. [PMID: 16860338].","journal-title":"J Psychiatr Res"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1089\/104454603322126313","volume":"13","author":"Geller D.A.","year":"2003","unstructured":"Geller DA, Biederman J, Stewart SE, Mullin B, Farrell C, Wagner KD, Emslie G, Carpenter D. J Child Adolesc Psychopharmacol, Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?,, 2003, 13,, S19-S29,[http:\/\/dx.doi.org\/10.1089\/1044546 03322126313]. [PMID: 12880497].","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","volume":"292","year":"2004","unstructured":". JAMA, Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.,Pediatric OCD treatment study (POTS) team, 2004, 292,, 1969-1976,[http:\/\/dx.doi.org\/10.1001\/jama.292.16.1969]. [PMID: 15507582].","journal-title":"JAMA"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.biopsych.2006.09.035","volume":"61","author":"March J.S.","year":"2007","unstructured":"March JS, Franklin ME, Leonard H, Garcia A, Moore P, Freeman J, Foa E. Biol Psychiatry, Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.,, 2007, 61,, 344-347,[http:\/\/ dx.doi.org\/10.1016\/j.biopsych.2006.09.035]. [PMID: 17241830].","journal-title":"Biol Psychiatry"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archpsyc.1994.03950040046006","volume":"51","author":"McDougle C.J.","year":"1994","unstructured":"McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH. Arch Gen Psychiatry, Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.,, 1994, 51,, 302-308,[http:\/\/dx.doi.org\/10.1001\/archpsyc. 1994.03950040046006]. [PMID: 8161290].","journal-title":"Arch Gen Psychiatry"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fnins.2016.00416","volume":"10","author":"Gerasch S.","year":"2016","unstructured":"Gerasch S, Kanaan AS, Jakubovski E, M\u00fcller-Vahl KR. Front Neurosci, Aripiprazole improves associated comorbid conditions in addition to tics in adult patients with Gilles de la Tourette Syndrome.,, 2016, 10,, 416-,[http:\/\/dx.doi.org\/10.3389\/fnins.2016. 00416]. [PMID: 27672358].","journal-title":"Front Neurosci"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/JCP.0b013e31825ac2cb","volume":"32","author":"Wenzel C.","year":"2012","unstructured":"Wenzel C, Kleimann A, Bokemeyer S, M\u00fcller-Vahl KR. J Clin Psychopharmacol, Aripiprazole for the treatment of Tourette syndrome: a case series of 100 patients.,, 2012, 32,, 548-550,[http:\/\/dx.doi.org\/10.1097\/JCP.0b013e31825ac2cb]. [PMID: 22722499].","journal-title":"J Clin Psychopharmacol"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/164905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T17:49:11Z","timestamp":1720547351000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/164905\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,7,25]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x16666180828095131","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-01-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}